Sumitomo Mitsui DS Asset Management’s Sabra Healthcare REIT SBRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.12M | Hold |
57,615
| – | – | 0.01% | 615 |
|
|
2026
Q1 | $1.11M | Hold |
57,615
| – | – | 0.01% | 605 |
|
|
2025
Q4 | $1.09M | Buy |
57,615
+6,223
| +12% | +$115K | 0.01% | 606 |
|
|
2025
Q3 | $958K | Hold |
51,392
| – | – | 0.01% | 619 |
|
|
2025
Q2 | $948K | Hold |
51,392
| – | – | 0.01% | 620 |
|
|
2025
Q1 | $898K | Buy |
51,392
+7,161
| +16% | +$121K | 0.01% | 642 |
|
|
2024
Q4 | $766K | Hold |
44,231
| – | – | 0.01% | 664 |
|
|
2024
Q3 | $823K | Hold |
44,231
| – | – | 0.01% | 652 |
|
|
2024
Q2 | $681K | Buy |
44,231
+6,666
| +18% | +$95.3K | 0.01% | 660 |
|
|
2024
Q1 | $555K | Hold |
37,565
| – | – | 0.01% | 675 |
|
|
2023
Q4 | $536K | Hold |
37,565
| – | – | 0.01% | 699 |
|
|
2023
Q3 | $524K | Buy |
37,565
+4,886
| +15% | +$62.5K | 0.01% | 675 |
|
|
2023
Q2 | $385K | Hold |
32,679
| – | – | 0.01% | 710 |
|
|
2023
Q1 | $376K | Hold |
32,679
| – | – | 0.01% | 702 |
|
|
2022
Q4 | $406K | Hold |
32,679
| – | – | 0.01% | 686 |
|
|
2022
Q3 | $429K | Buy |
32,679
+4,456
| +16% | +$65.8K | 0.01% | 655 |
|
|
2022
Q2 | $394K | Buy |
28,223
+5,345
| +23% | +$71.5K | 0.01% | 671 |
|
|
2022
Q1 | $341K | Buy |
22,878
+2,576
| +13% | +$35.2K | 0.01% | 711 |
|
|
2021
Q4 | $274K | Hold |
20,302
| – | – | 0.01% | 732 |
|
|
2021
Q3 | $298K | Buy |
20,302
+2,199
| +12% | +$37.1K | 0.01% | 711 |
|
|
2021
Q2 | $329K | Buy |
18,103
+3,271
| +22% | +$58.2K | 0.01% | 713 |
|
|
2021
Q1 | $257K | Buy |
14,832
+1,337
| +10% | +$23.5K | 0.01% | 712 |
|
|
2020
Q4 | $234K | Hold |
13,495
| – | – | 0.01% | 711 |
|
|
2020
Q3 | $186K | Hold |
13,495
| – | – | 0.01% | 704 |
|
|
2020
Q2 | $194K | Buy |
13,495
+3,352
| +33% | +$44.1K | 0.01% | 696 |
|
|
2020
Q1 | $110K | Hold |
10,143
| – | – | ﹤0.01% | 673 |
|
|
2019
Q4 | $216K | Buy |
+10,143
| New | +$227K | 0.01% | 706 |
|
|
2019
Q2 | – | Sell |
-98,567
| Closed | -$1.92M | – | 778 |
|
|
2019
Q1 | $1.92M | Sell |
98,567
-69,430
| -41% | -$1.32M | 0.03% | 362 |
|
|
2018
Q4 | $2.77M | Sell |
167,997
-1,641
| -1% | -$33K | 0.05% | 256 |
|
|
2018
Q3 | $3.92M | Buy |
+169,638
| New | +$3.84M | 0.06% | 230 |
|
|
2015
Q4 | – | Sell |
-113,266
| Closed | -$2.63M | – | 716 |
|
|
2015
Q3 | $2.63M | Buy |
+113,266
| New | +$2.89M | 0.09% | 213 |
|
|
2015
Q2 | – | Sell |
-342,008
| Closed | -$11.3M | – | 730 |
|
|
2015
Q1 | $11.3M | Buy |
+342,008
| New | +$11.1M | 0.34% | 88 |
|
|
2014
Q2 | – | Sell |
-8,150
| Closed | -$227K | – | 787 |
|
|
2014
Q1 | $227K | Sell |
8,150
-1,050
| -11% | -$28.8K | 0.01% | 769 |
|
|
2013
Q4 | $240K | Hold |
9,200
| – | – | 0.01% | 765 |
|
|
2013
Q3 | $211K | Buy |
9,200
+100
| +1% | +$2.46K | 0.01% | 739 |
|
|
2013
Q2 | $237K | Buy |
+9,100
| New | +$263K | 0.01% | 730 |
|
Other funds holding SBRA
CIM
Sumitomo Mitsui DS Asset Management's SBRA Position: Q2 2026 in Review
Sumitomo Mitsui DS Asset Management held its Sabra Healthcare REIT (SBRA) position steady in Q2 2026 at 57,615 shares worth $1.12M. The position accounts for 0.01% of the portfolio, ranked #615.
Sumitomo Mitsui DS Asset Management first reported a position in SBRA in Q2 2013 and has held it in 36 quarters since. The position peaked at $11.3M in Q1 2015. 463 funds tracked by Wall St. Rank hold SBRA as of Q2 2026.
- Sumitomo Mitsui DS Asset Management held 57,615 shares of Sabra Healthcare REIT worth $1.12M as of Q2 2026.
- Sumitomo Mitsui DS Asset Management left its Sabra Healthcare REIT share count unchanged in Q2 2026.
- Sabra Healthcare REIT made up 0.01% of Sumitomo Mitsui DS Asset Management's portfolio in Q2 2026, its #615 holding.
- Sumitomo Mitsui DS Asset Management first reported a position in Sabra Healthcare REIT in Q2 2013 and has held it in 36 quarters since.
- Sumitomo Mitsui DS Asset Management's Sabra Healthcare REIT position peaked at $11.3M in Q1 2015.
- 463 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q2 2026.
Based on Sumitomo Mitsui DS Asset Management's 13F filing for Q2 2026, filed 22 Jul 2026.